The Association of MicroRNA21-155 Levels With Acute Side Effects In Patients With Stage III NSCLC With Definitive CRT
CompletedOBSERVATIONAL
Enrollment
21
Participants
Timeline
Start Date
October 5, 2019
Primary Completion Date
April 29, 2020
Study Completion Date
August 15, 2020
Conditions
Non-small Cell Lung Cancer Stage III
Trial Locations (1)
06590
Ankara University Medicine School Radiation Oncology, Ankara
All Listed Sponsors
lead
Ankara University
OTHER
NCT06015815 - The Association of MicroRNA21-155 Levels With Acute Side Effects In Patients With Stage III NSCLC With Definitive CRT | Biotech Hunter | Biotech Hunter